Citadel Advisors
ONEM

Citadel Advisors’s 1Life Healthcare ONEM Stock Holding History

Citadel Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,100
Closed -$35.1K – 16106
2022
Q4 		$35.1K Sell
2,100
-76,400
-97% -$1.29M ﹤0.01% 12562
2022
Q3 		$1.35M Buy
78,500
+30,400
+63% +$477K ﹤0.01% 6371
2022
Q2 		$377K Sell
48,100
-34,900
-42% -$300K ﹤0.01% 9278
2022
Q1 		$920K Sell
83,000
-107,900
-57% -$1.21M ﹤0.01% 7909
2021
Q4 		$3.35M Buy
190,900
+4,900
+3% +$95K ﹤0.01% 5123
2021
Q3 		$3.77M Buy
186,000
+131,600
+242% +$3.38M ﹤0.01% 4874
2021
Q2 		$1.8M Sell
54,400
-76,200
-58% -$2.88M ﹤0.01% 6862
2021
Q1 		$5.1M Buy
130,600
+92,400
+242% +$4.34M ﹤0.01% 4213
2020
Q4 		$1.67M Buy
38,200
+8,200
+27% +$280K ﹤0.01% 5753
2020
Q3 		$851K Buy
30,000
+21,900
+270% +$691K ﹤0.01% 6325
2020
Q2 		$294K Buy
+8,100
New +$228K ﹤0.01% 7940

Citadel Advisors's ONEM Position: Q1 2023 in Review

Citadel Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,702,490 shares — an estimated $28.4M sold.

Citadel Advisors first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $31.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Citadel Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,702,490 1Life Healthcare shares in Q1 2023, an estimated $28.4M.
  • Citadel Advisors first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Citadel Advisors's 1Life Healthcare position peaked at $31.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.